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Following the publication of the original article [1], the 
authors noticed an error in the units for Tmax in the 
first of the two tables in Additional file 2, “Pharmacoki-
netic parameters (median, IQR) of amodiaquine and 
desethylamodiaquine following artesunate-amodiaquine 
fixed-dose combination treatment of Ghanaian patients 
with uncomplicated P. falciparum malaria, by study site 
and age category”.
In the table under sub-heading, Navrongo Health 
Research Centre:
 i. The units of measure of Tmax (hours) for Amodi-
aquine should read Tmax (days)
 ii. The units of measure of Tmax (hours) for Deseth-
ylamodiaquine should read Tmax (days)
 iii. The units of t½ (days) for Desthylamodiaquine 
should read  t½ (hours)
The file has been corrected in the original article 
and the correct version of the file can be found in this 
correction.
The authors apologize for any inconvenience caused.
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